-
-
-
-
-
-
-
Collegium Pharmaceutical (COLL) PT Raised to $45 at Piper Sandler
-
-
-
-
-
-
-
Collegium Pharma (COLL) Tops Q3 EPS by 37c ; Offers Guidance
-
-
-
-
-
-
-
Avalo Therapuetics (AVTX) Appoints Michael Heffernan as Chairman of the Board
-
-
-
-
-
-
-
Collegium Pharmaceutical (COLL) PT Lowered to $40 at Jefferies
-
-
-
-
-
-
-
Collegium Pharma (COLL) Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
479,041 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


